---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-086830"
form_type: "8-K"
ticker: "DFTX"
cik: "0001813814"
company_name: "Definium Therapeutics, Inc."
filed_at: "2025-06-16T23:59:59+00:00"
generated_at: "2026-05-19T06:44:44.145435+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# MindMed shareholders approve 2025 Equity Incentive Plan authorizing 4.5M new shares

## Summary
- Plan replaces prior stock option and restricted share unit plans; 4,500,000 common shares reserved.
- All six director nominees (Robert Barrow, Dr. Suzanne Bruhn, Dr. Roger Crystal, David Gryska, Andreas Krebs, Carol A. Vallone) elected with >99% votes for each.
- KPMG LLP ratified as independent auditor for the next year (42,583,160 for, 267,331 withheld).
- Plan approved by shareholders: 28,452,155 for, 581,911 against, 110,688 abstain, 13,705,737 broker non-votes.
- Annual meeting held June 12, 2025; 56.7% of outstanding shares voted, quorum present.

## SEC filing metadata
- accession: 0000950170-25-086830
- form_type: 8-K
- ticker: DFTX
- cik: 0001813814
- company_name: Definium Therapeutics, Inc.
- filed_at: 2025-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1813814/000095017025086830/0000950170-25-086830-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1813814/000095017025086830/mnmd-20250616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-086830
- JSON: https://secwatch.observer/filing/0000950170-25-086830.json
- Plain text: https://secwatch.observer/filing/0000950170-25-086830.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.